COMPARATIVE EVALUATION OF QUALITY ASSURANCE PRACTICES ACROSS BRANDED, GENERIC, AND ORPHAN DRUGS

Authors

  • Bala Tripura Sundari Majji, Raghava.D, Nageswara Rao.K, Naga Sravani.P Author

DOI:

https://doi.org/10.48047/

Keywords:

Quality Assurance, Branded Drugs, Generic Drugs, Orphan Drugs, GMP, QbD, Pharmaceutical Regulation, Validation, Risk Management

Abstract

The pharmaceutical industry encompasses three primary categories of drugs—branded, generic, and orphan—each subject to differing regulatory, economic, and operational environments. While quality assurance

Downloads

Download data is not yet available.

Downloads

Published

2025-10-07

Issue

Vol. 16 No. 10 (2025): Volume 16 Issue 10 (2025)

Section

Articles